海新能科(300072.SZ):擬公開掛牌轉讓四川鑫達55%股權
格隆匯4月15日丨海新能科(300072.SZ)公佈,公司於2024年04月15日召開了第六屆董事會第九次會議,審議通過了《關於擬公開掛牌轉讓控股子公司四川鑫達新能源科技有限公司55%股權並進行信息預披露的議案》,根據公司戰略發展需要,為優化公司產業結構,減少公司經營壓力,減輕公司經營風險,進一步優化公司資產質量,加快公司產業轉型升級步伐,集中資源聚焦公司生物能源產業,提高資源配置效率,同意公司通過北京產權交易所公開掛牌轉讓所持控股子公司四川鑫達新能源科技有限公司(簡稱“四川鑫達”或“標的公司”)55%股權,徵集擬轉讓股權的潛在受讓方。若本次交易順利完成,公司將不再持有四川鑫達的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.